Eighth International Adrenal Cancer Symposium Brescia, Italy, September 30 to October 1-2, 2021

Alfredo Berruti^{1

2

3}, Massimo Terzolo^{4

5

6}, Sebastiano Filetti^{4

5

6}

Affiliations

¹ Department of Medical and Surgical Specialties Radiological Sciences, and Public Health, Medical Oncology, University of Brescia at ASST Spedali Civili, Brescia, Italy. alfredo.berruti@unibs.it.
² Department of Clinical and Biological Sciences, Internal Medicine, San Luigi Gonzaga Hospital, University of Turin, Orbassano, Italy. alfredo.berruti@unibs.it.
³ School of Health, Unitelma Sapienza University of Rome, Rome, Italy. alfredo.berruti@unibs.it.
⁴ Department of Medical and Surgical Specialties Radiological Sciences, and Public Health, Medical Oncology, University of Brescia at ASST Spedali Civili, Brescia, Italy.
⁵ Department of Clinical and Biological Sciences, Internal Medicine, San Luigi Gonzaga Hospital, University of Turin, Orbassano, Italy.
⁶ School of Health, Unitelma Sapienza University of Rome, Rome, Italy.

PMID: 35867326
PMCID: PMC9305057
DOI: 10.1007/s12020-022-03147-z

Editorial

Eighth International Adrenal Cancer Symposium Brescia, Italy, September 30 to October 1-2, 2021

Alfredo Berruti et al. Endocrine. 2022 Sep.

. 2022 Sep;77(3):409-410.

doi: 10.1007/s12020-022-03147-z.

Authors

Alfredo Berruti^{1

2

3}, Massimo Terzolo^{4

5

6}, Sebastiano Filetti^{4

5

6}

Affiliations

¹ Department of Medical and Surgical Specialties Radiological Sciences, and Public Health, Medical Oncology, University of Brescia at ASST Spedali Civili, Brescia, Italy. alfredo.berruti@unibs.it.
² Department of Clinical and Biological Sciences, Internal Medicine, San Luigi Gonzaga Hospital, University of Turin, Orbassano, Italy. alfredo.berruti@unibs.it.
³ School of Health, Unitelma Sapienza University of Rome, Rome, Italy. alfredo.berruti@unibs.it.
⁴ Department of Medical and Surgical Specialties Radiological Sciences, and Public Health, Medical Oncology, University of Brescia at ASST Spedali Civili, Brescia, Italy.
⁵ Department of Clinical and Biological Sciences, Internal Medicine, San Luigi Gonzaga Hospital, University of Turin, Orbassano, Italy.
⁶ School of Health, Unitelma Sapienza University of Rome, Rome, Italy.

PMID: 35867326
PMCID: PMC9305057
DOI: 10.1007/s12020-022-03147-z

No abstract available

PubMed Disclaimer

Comment on

Liquid biopsy for the assessment of adrenal cancer heterogeneity: where do we stand?
Perge P, Nyirő G, Vékony B, Igaz P. Perge P, et al. Endocrine. 2022 Sep;77(3):425-431. doi: 10.1007/s12020-022-03066-z. Epub 2022 May 13. Endocrine. 2022. PMID: 35552979 Free PMC article. Review.
Supportive therapies in patients with advanced adrenocortical carcinoma submitted to standard EDP-M regimen.
Turla A, Laganà M, Grisanti S, Abate A, Ferrari VD, Cremaschi V, Sigala S, Consoli F, Cosentini D, Berruti A. Turla A, et al. Endocrine. 2022 Sep;77(3):438-443. doi: 10.1007/s12020-022-03075-y. Epub 2022 May 14. Endocrine. 2022. PMID: 35567656 Free PMC article. Review.
FGF/FGFR signaling in adrenocortical development and tumorigenesis: novel potential therapeutic targets in adrenocortical carcinoma.
Tamburello M, Altieri B, Sbiera I, Sigala S, Berruti A, Fassnacht M, Sbiera S. Tamburello M, et al. Endocrine. 2022 Sep;77(3):411-418. doi: 10.1007/s12020-022-03074-z. Epub 2022 May 18. Endocrine. 2022. PMID: 35583844 Free PMC article. Review.
An update on adrenocortical cell lines of human origin.
Sigala S, Rossini E, Abate A, Tamburello M, Bornstein SR, Hantel C. Sigala S, et al. Endocrine. 2022 Sep;77(3):432-437. doi: 10.1007/s12020-022-03112-w. Epub 2022 Jun 28. Endocrine. 2022. PMID: 35764904 Free PMC article. Review.
New endpoints in adrenocortical carcinoma studies: a mini review.
Faron M, Lamartina L, Hescot S, Moog S, Deschamps F, Roux C, Libe R, Durand-Labrunie J, Al Ghuzlan A, Hadoux J, Baudin E. Faron M, et al. Endocrine. 2022 Sep;77(3):419-424. doi: 10.1007/s12020-022-03128-2. Epub 2022 Jul 23. Endocrine. 2022. PMID: 35869971 Review.

References

1. Grisanti S, Cosentini D, Sigala S, Berruti A. Molecular genotyping of adrenocortical carcinoma: a systematic analysis of published literature 2019-2021. Curr. Opin. Oncol. 2022;34(1):19–28. doi: 10.1097/CCO.0000000000000799. - DOI - PMC - PubMed
1. Grisanti S, Cosentini D, Laganà M, et al. Are we failing in treatment of adrenocortical carcinoma? Lights and shadows of molecular signatures. Curr. Opin. Endocr. Metab. Res. 2019;8:80–87. doi: 10.1016/j.coemr.2019.07.007. - DOI
1. Schteingart DE, Doherty GM, Gauger PG, Giordano TJ, Hammer GD, Korobkin M, Worden FP. Management of patients with adrenal cancer: recommendations of an international consensus conference. Endocr. Relat. Cancer. 2005;12(3):667–680. doi: 10.1677/erc.1.01029. - DOI - PubMed
1. P. Perge, G. Nyirő, B. Vékony, P. Igaz, Liquid biopsy for the assessment of adrenal cancer heterogeneity: where do we stand? Endocrine. (2022). 10.1007/s12020-022-03066-z. Online ahead of print - PMC - PubMed
1. M. Tamburello, B. Altieri, I. Sbiera, S. Sigala, A. Berruti, M. Fassnacht, S. Sbiera, FGF/FGFR signaling in adrenocortical development and tumorigenesis: novel potential therapeutic targets in adrenocortical carcinoma. Endocrine. (2022). 10.1007/s12020-022-03074-z. Epub ahead of print - PMC - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Eighth International Adrenal Cancer Symposium Brescia, Italy, September 30 to October 1-2, 2021

Affiliations

Eighth International Adrenal Cancer Symposium Brescia, Italy, September 30 to October 1-2, 2021

Authors

Affiliations

Comment on

References

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources

Medical